Lipofuscin: Wear Pigment or Alarm Signal for Cardiac AlloGraft Vasculopathy?
Anca Otilia Farcas, Mihai Ciprian Stoica, Septimiu Voidazan, Carmen Corina Radu et al. • Diagnostics
(2026)
Background: CAV (cardiac allograft vasculopathy) is considered the leading cause of late post-transplant mortality and affects approximately 50% of transplant patients at 10 years post-transplant. Its etiopathogenetic mechanism is considere...
DOAJ
Open Access (DOAJ)
DOI:
10.3390/diagnostics16152432